BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 23266801)

  • 1. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
    Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
    Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
    Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
    J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature.
    Becker K; Di Donato N; Holder-Espinasse M; Andrieux J; Cuisset JM; Vallée L; Plessis G; Jean N; Delobel B; Thuresson AC; Annerén G; Ravn K; Tümer Z; Tinschert S; Schrock E; Jønch AE; Hackmann K
    Eur J Med Genet; 2012; 55(8-9):490-7. PubMed ID: 22561202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel de novo 1.8 Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features.
    Preiksaitiene E; Männik K; Dirse V; Utkus A; Ciuladaite Z; Kasnauskiene J; Kurg A; Kučinskas V
    Eur J Med Genet; 2012 Nov; 55(11):656-9. PubMed ID: 22842074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A de novo 1.13 Mb microdeletion in 12q13.13 associated with congenital distal arthrogryposis, intellectual disability and mild dysmorphism.
    Jonsson DI; Ludvigsson P; Aradhya S; Sigurdardottir S; Steinarsdottir M; Hauksdottir H; Jonsson JJ
    Eur J Med Genet; 2012 Jun; 55(6-7):437-40. PubMed ID: 22534424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH.
    Harvard C; Malenfant P; Koochek M; Creighton S; Mickelson EC; Holden JJ; Lewis ME; Rajcan-Separovic E
    Clin Genet; 2005 Apr; 67(4):341-51. PubMed ID: 15733271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of 4.4 Mb at 2q33.2q33.3 May Cause Growth Deficiency in a Patient with Mental Retardation, Facial Dysmorphic Features and Speech Delay.
    Papoulidis I; Paspaliaris V; Papageorgiou E; Siomou E; Dagklis T; Sotiriou S; Thomaidis L; Manolakos E
    Cytogenet Genome Res; 2015; 145(1):19-24. PubMed ID: 25925190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of two patients with overlapping de novo microdeletions in 2p14-p15 and mild mental retardation.
    Wohlleber E; Kirchhoff M; Zink AM; Kreiss-Nachtsheim M; Küchler A; Jepsen B; Kjaergaard S; Engels H
    Eur J Med Genet; 2011; 54(1):67-72. PubMed ID: 20950717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 2p15p16.1 microdeletion syndrome: 2.5 Mb deletion in a patient with renal anomalies, intractable seizures and a choledochal cyst.
    Hucthagowder V; Liu TC; Paciorkowski AR; Thio LL; Keller MS; Anderson CD; Herman T; Dehner LP; Grange DK; Kulkarni S
    Eur J Med Genet; 2012; 55(8-9):485-9. PubMed ID: 22579565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy.
    Valetto A; Orsini A; Bertini V; Toschi B; Bonuccelli A; Simi F; Sammartino I; Taddeucci G; Simi P; Saggese G
    Eur J Med Genet; 2012 May; 55(5):362-6. PubMed ID: 22548977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17q21.31 microdeletion associated with infantile spasms.
    Wray CD
    Eur J Med Genet; 2013 Jan; 56(1):59-61. PubMed ID: 23123321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A de novo 3.57 Mb microdeletion in 8q12.3q13.2 in a patient with mild intellectual disability and epilepsy.
    Verhoeven WM; Egger JI; Feenstra I; de Leeuw N
    Eur J Med Genet; 2012 May; 55(5):358-61. PubMed ID: 22138216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypic and genetic analysis of a girl with multiple congenital deformities due to 2p15-p16.1 microdeletion syndrome].
    Wu D; Wang H; Zhang H; Hou Q; Qin L; Wang T; Xiao H; Liao S; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):823-6. PubMed ID: 26663057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome.
    Lévy J; Coussement A; Dupont C; Guimiot F; Baumann C; Viot G; Passemard S; Capri Y; Drunat S; Verloes A; Pipiras E; Benzacken B; Dupont JM; Tabet AC
    Am J Med Genet A; 2017 Aug; 173(8):2081-2087. PubMed ID: 28573701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of SNP arrays in diagnosis of deletion 2p11.2-p12.
    Rocca MS; Fabretto A; Faletra F; Carlet O; Skabar A; Gasparini P; Pecile V
    Gene; 2012 Jan; 492(1):315-8. PubMed ID: 22062632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1 Mb de novo deletion within 11q13.1q13.2 in a boy with mild intellectual disability and minor dysmorphic features.
    Floor K; Barøy T; Misceo D; Kanavin OJ; Fannemel M; Frengen E
    Eur J Med Genet; 2012 Dec; 55(12):695-9. PubMed ID: 22986108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient.
    Varela MC; Krepischi-Santos AC; Paz JA; Knijnenburg J; Szuhai K; Rosenberg C; Koiffmann CP
    Cytogenet Genome Res; 2006; 114(1):89-92. PubMed ID: 16717456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children.
    Zahir F; Firth HV; Baross A; Delaney AD; Eydoux P; Gibson WT; Langlois S; Martin H; Willatt L; Marra MA; Friedman JM
    J Med Genet; 2007 Sep; 44(9):556-61. PubMed ID: 17545556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.